Title Image

R&D

HND-027
HND-033
Indication Oncology
Status CDMO Tech-transfer ongoing.
Product Advantages Handa is utilizing its ONCORE™ technology to develop improved versions of Oncology drug for reducing the risk associated with sever side effect and improve bioavailability.
Potential Market Oncology market value is $133 billion in 2017.